4 recruiting, 2 active not recruiting, 1 not yet recruiting. 4 Phase 1, 3 Phase 2, 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Recruiting 2, Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 3 | Recruiting 2, Active not recruiting 1 |
| Early Phase 1 | 2 | Recruiting 2 |
Follow Radiopharm Theranostics, Ltd: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors. LNTH-2403 - Imaging, Colorectal Cancer | Phase 1 | Not yet recruiting | Radiopharm Theranostics, Ltd | 16 | 2026-10-30 | 2026-08-12 |
| A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC 161Tb RAD402 - Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | Recruiting | Radiopharm Theranostics, Ltd | 73 | 2026-03-05 | 2026-04-01 |
| 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors 177Lu-BetaBart, BetaBart + unlabeled BetaBart - Castration-Resistant Prostate Cancer (CRPC), Colorectal Cancer | Phase 1 / Phase 2 | Recruiting | Radiopharm Theranostics, Ltd | 61 | 2026-02-23 | 2026-10-01 |
| HEAT Trial (HER2 Antibody Therapy With Lutetium-177) 177Lu-RAD202 - HER2 Gene Mutation, Advanced Solid Tumors | Early Phase 1 | Recruiting | Radiopharm Theranostics, Ltd | 30 | 2025-02-12 | 2026-09-24 |
| Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain Metastases RAD101 (18F-FPIA) - Brain Metastases From Solid Tumors | Phase 2 | Active not recruiting | Radiopharm Theranostics, Ltd | 30 | 2024-12-13 | 2026-08-12 |
| 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors 177Lu-RAD204 - PDL1 Gene Mutation, Non Small Cell Lung Cancer | Early Phase 1 | Recruiting | Radiopharm Theranostics, Ltd | 30 | 2024-06-03 | 2026-02-19 |
| Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors RAD301 ([68Ga]-RAD301) - Healthy Volunteers, Pancreatic Ductal Adenocarcinoma | Phase 1 | Active not recruiting | Radiopharm Theranostics, Ltd | 9 | 2023-11-09 | 2026-09-14 |
Carcinoma, Non-Small-Cell Lung (4) · Endometrial Neoplasms (3) · Squamous Cell Carcinoma of Head and Neck (3) · Triple Negative Breast Neoplasms (3) · Colorectal Neoplasms (2) · Esophageal Squamous Cell Carcinoma (2) · Ovarian Neoplasms (2) · Small Cell Lung Carcinoma (2) · Uterine Cervical Neoplasms (2) · Brain Neoplasms (1) · Melanoma (1) · Sarcoma (1) · Turcot syndrome (1)
Australia (4) · United States (3)